Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
2025-05-01 22:35:30 ET
Bio-Rad Laboratories, Inc. (BIO)
Q1 2025 Earnings Conference Call
May 1, 2025, 05:30 PM ET
Company Participants
Edward Chung - Head of Investor Relations
Jon DiVincenzo - President and Chief Operating Officer
Roop Lakkaraju - Executive Vice President and Chief Financial Officer
Norman Schwartz - Chief Executive Officer
Conference Call Participants
Patrick Donnelly - Citigroup
Dan Leonard - UBS
Brandon Couillard - Wells Fargo
Conor McNamara - RBC Capital Markets
Jack Meehan - Nephron Research
Presentation
Operator
Ladies and gentlemen, thank you for standing by. My name is Desyree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad First Quarter 2025 Earnings Results Conference Call and Webcast. [Operator Instructions]
I would now like to turn the conference over to Edward Chung, Head of Investor Relations. You may begin.
Edward Chung
Thanks, Desyree. Good afternoon, everyone, and thank you for joining us. Today, we will review the first quarter 2025 financial results and provide an update on key business trends for Bio-Rad.
With me on the call today are Norman Schwartz, our Chief Executive Officer; Jon DiVincenzo, President and Chief Operating Officer; and Roop Lakkaraju, Executive Vice President and Chief Financial Officer.
Before we begin our review, I would like to remind everyone that we'll be making forward-looking statements about management's goals, plans, and expectations, our future financial performance, and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals, and expectations. You should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC, where we discuss in detail the risk factors in our business. The company does not intend to update any forward-looking statements made during the call today....
Read the full article on Seeking Alpha
For further details see:
Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call TranscriptNASDAQ: BIO
BIO Trading
11.5% G/L:
$277.42 Last:
471,754 Volume:
$274.72 Open:










